A probiotic yeast-based immunotherapy against Clostridioides difficile infection-Reference-Cited by-同舟云学术

A probiotic yeast-based immunotherapy against Clostridioides difficile infection

Published:2020-10-28 Issue:567 Volume:12 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Chen Kevin¹^ORCID,Zhu Yixuan²^ORCID,Zhang Yongrong¹,Hamza Therwa¹^ORCID,Yu Hua³^ORCID,Saint Fleur Ashley¹,Galen James²^ORCID,Yang Zhiyong³,Feng Hanping¹^ORCID

Affiliation:

1. Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, MD 21201, USA.

2. Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

3. FZata Inc., Halethorpe, MD 21227, USA.

Abstract

An engineered yeast-based immunotherapy shows prophylactic and therapeutic efficacy against C. difficile infection in mice.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference97 articles.

1. Clostridium difficile— More Difficult Than Ever

2. Clostridium difficileInfection in Patients Discharged from US Short-stay Hospitals, 1996–20031

3. Burden ofClostridium difficileInfection in the United States

4. Burden ofClostridium difficileInfection in the United States

5. Can we identify patients at high risk of recurrent Clostridium difficile infection?

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease;Journal of Controlled Release;2024-10

2. Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches;International Journal of Molecular Sciences;2024-09-08

3. De novo design of potent inhibitors of Clostridioides difficile toxin B;2024-08-26

4. Strategic approaches for designing yeast strains as protein secretion and display platforms;Critical Reviews in Biotechnology;2024-08-13

5. Programming Probiotics: Diet-Responsive Gene Expression and Colonization Control in Engineered S. boulardii;ACS Synthetic Biology;2024-05-24